205 related articles for article (PubMed ID: 19035614)
1. Syntheses of high-valent fac-[99mTcO3]+ complexes and [3+2] cycloadditions with alkenes in water as a direct labelling strategy.
Braband H; Tooyama Y; Fox T; Alberto R
Chemistry; 2009; 15(3):633-8. PubMed ID: 19035614
[TBL] [Abstract][Full Text] [Related]
2. Water-stable fac-{TcO₃}⁺ complexes - a new field of technetium chemistry.
Braband H
Chimia (Aarau); 2011; 65(10):776-81. PubMed ID: 22054130
[TBL] [Abstract][Full Text] [Related]
3. fac-[TcO3(tacn)]+: a versatile precursor for the labelling of pharmacophores, amino acids and carbohydrates through a new ligand-centred labelling strategy.
Braband H; Tooyama Y; Fox T; Simms R; Forbes J; Valliant JF; Alberto R
Chemistry; 2011 Nov; 17(46):12967-74. PubMed ID: 21971703
[TBL] [Abstract][Full Text] [Related]
4. Combining bifunctional chelator with (3 + 2)-cycloaddition approaches: synthesis of dual-function technetium complexes.
Braband H; Imstepf S; Benz M; Spingler B; Alberto R
Inorg Chem; 2012 Apr; 51(7):4051-7. PubMed ID: 22416667
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biological evaluation of neutral nitrido technetium(V) mixed ligand complexes containing dithiolates and aminodiphosphines. A novel system for linking technetium to biomolecules.
Bolzati C; Benini E; Cazzola E; Jung C; Tisato F; Refosco F; Pietzsch HJ; Spies H; Uccelli L; Duatti A
Bioconjug Chem; 2004; 15(3):628-37. PubMed ID: 15149191
[TBL] [Abstract][Full Text] [Related]
6. Caution to HPLC analysis of tricarbonyl technetium radiopharmaceuticals: an example of changing constitution of complexes in column.
Chen X; Guo Y; Liu B
J Pharm Biomed Anal; 2007 Mar; 43(4):1576-9. PubMed ID: 17187955
[TBL] [Abstract][Full Text] [Related]
7. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
8. Pyrazolyl derivatives as bifunctional chelators for labeling tumor-seeking peptides with the fac-[M(CO)3]+ moiety (M = 99mTc, Re): synthesis, characterization, and biological behavior.
Alves S; Paulo A; Correia JD; Gano L; Smith CJ; Hoffman TJ; Santos I
Bioconjug Chem; 2005; 16(2):438-49. PubMed ID: 15769099
[TBL] [Abstract][Full Text] [Related]
9. Re(CO)(3) complexes synthesized via an improved preparation of aqueous fac-[Re(CO)(3)(H(2)O)(3)](+) as an aid in assessing (99m)Tc imaging agents. Structural characterization and solution behavior of complexes with thioether-bearing amino acids as tridentate ligands.
He H; Lipowska M; Xu X; Taylor AT; Carlone M; Marzilli LG
Inorg Chem; 2005 Jul; 44(15):5437-46. PubMed ID: 16022542
[TBL] [Abstract][Full Text] [Related]
10. Aqueous synthesis of derivatized cyclopentadienyl complexes of technetium and rhenium directed toward radiopharmaceutical application.
Bernard J; Ortner K; Spingler B; Pietzsch HJ; Alberto R
Inorg Chem; 2003 Feb; 42(4):1014-22. PubMed ID: 12588133
[TBL] [Abstract][Full Text] [Related]
11. A novel (99m)Tc labelling strategy for the development of silica based particles for medical applications.
Wuillemin MA; Stuber WT; Fox T; Reber MJ; Brühwiler D; Alberto R; Braband H
Dalton Trans; 2014 Mar; 43(11):4260-3. PubMed ID: 24326345
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and biological evaluation of technetium(III) complexes with tridentate/bidentate S,E,S/P,S coordination (E = O, N(CH(3)), S): a novel approach to robust technetium chelates suitable for linking the metal to biomolecules.
Pietzsch HJ; Seifert S; Syhre R; Tisato F; Refosco F; Leibnitz P; Spies H
Bioconjug Chem; 2003; 14(1):136-43. PubMed ID: 12526702
[TBL] [Abstract][Full Text] [Related]
13. Rhenium and technetium tricarbonyl complexes anchored by pyrazole-based tripods: novel lead structures for the design of myocardial imaging agents.
Maria L; Cunha S; Videira M; Gano L; Paulo A; Santos IC; Santos I
Dalton Trans; 2007 Jul; (28):3010-9. PubMed ID: 17622418
[TBL] [Abstract][Full Text] [Related]
14. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules.
Schibli R; La Bella R; Alberto R; Garcia-Garayoa E; Ortner K; Abram U; Schubiger PA
Bioconjug Chem; 2000; 11(3):345-51. PubMed ID: 10821650
[TBL] [Abstract][Full Text] [Related]
15. Assessment of macrocyclic triamine ligands as synthons for organometallic 99mTc radiopharmaceuticals.
Suzuki K; Shimmura N; Thipyapong K; Uehara T; Akizawa H; Arano Y
Inorg Chem; 2008 Apr; 47(7):2593-600. PubMed ID: 18269240
[TBL] [Abstract][Full Text] [Related]
16. '2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals.
Fuks L; Gniazdowska E; Kozminski P; Lyczko M; Mieczkowski J; Narbutt J
Appl Radiat Isot; 2010 Jan; 68(1):90-5. PubMed ID: 19766012
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and preliminary biological evaluation of the first (99m)Tc(I)-specific semi-rigid tridentate ligand based on a click chemistry strategy.
Guizani S; Malek Saied N; Picard C; Benoist E; Saidi M
J Labelled Comp Radiopharm; 2014 Mar; 57(3):158-63. PubMed ID: 24425684
[TBL] [Abstract][Full Text] [Related]
18. Relevance of the ligand exchange rate and mechanism of fac-[(CO)3M(H2O)3]+ (M = Mn, Tc, Re) complexes for new radiopharmaceuticals.
Grundler PV; Helm L; Alberto R; Merbach AE
Inorg Chem; 2006 Dec; 45(25):10378-90. PubMed ID: 17140248
[TBL] [Abstract][Full Text] [Related]
19. Syntheses of bifunctional 2,3-diamino propionic acid-based chelators as small and strong tripod ligands for the labelling of biomolecules with (99m)Tc.
Liu Y; Oliveira BL; Correia JD; Santos IC; Santos I; Spingler B; Alberto R
Org Biomol Chem; 2010 Jun; 8(12):2829-39. PubMed ID: 20445942
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
